Go Pro
OTCMKTS:CURLF

Curaleaf Q1 2025 Earnings Report

Curaleaf logo
$11.07 -0.15 (-1.34%)
As of 09/25/2026 03:57 PM Eastern

Curaleaf EPS Results

Actual EPS
-$0.21
Consensus EPS
-$0.21
Beat/Miss
Met Expectations
One Year Ago EPS
N/A

Curaleaf Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Curaleaf Announcement Details

Quarter
Q1 2025
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Curaleaf Earnings Headlines

Curaleaf (OTCMKTS:CURLF) Shares Up 7.8% - Time to Buy?
Shocking new footage just released
Gerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he says has never existed before. In a similar setup in the past, select investors saw $1,000 turn into over $1 million within a few years. Del Real just released a full video breakdown of what is driving this move and how to prepare.tc pixel
Curaleaf Added to FTSE Canada All Cap Index
See More Curaleaf Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Curaleaf? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Curaleaf and other key companies, straight to your email.

About Curaleaf

Curaleaf (OTCMKTS:CURLF) is a cannabis company that cultivates, processes, distributes and sells cannabis products in the United States and select international markets. Its operations include cannabis cultivation and processing facilities, retail dispensaries and wholesale distribution, serving both medical cannabis patients and adult-use consumers where permitted by law.

The company offers a broad portfolio of products, including cannabis flower, pre-rolls, vape products, concentrates, edibles, tinctures and other wellness-oriented products. Its portfolio has included the Curaleaf, Select, Grassroots and Find brands, which are sold through company-operated retail locations and third-party channels in applicable markets.

Curaleaf traces its roots to 2010 and has expanded through organic growth and acquisitions. In addition to its U.S. business, the company has pursued international opportunities, including medical cannabis activities in European markets such as Germany. Curaleaf is led by Executive Chairman Boris Jordan and operates within a highly regulated industry subject to differing state, federal and international laws.

View Curaleaf Profile